PatenSee vs Pomicell
PatenSee vs Pomicell, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: PatenSee is on 25/100 and Pomicell on 46/100.
Where each one leads
PatenSee
- agent readiness: 39/100 against 21/100
- domain rating: 8/100 against 4/100
Pomicell
- our overall score: 46/100 against 25/100
- LinkedIn following: 2,777 against 329
At a glance
| Measure | PatenSee | Pomicell |
|---|---|---|
| What it is | Clinical-stage medical device company developing a contactless, optical imaging system for rapid vascular access monitoring in dialysis patients. | Integrates scientific big data with patient medical records for personalized disease models and AI-driven insights. |
| Category | Healthcare, Disease, Detection, Prevention | Healthcare, Biotech, Decision Support, Analytics |
| Sells toBusiness model | B2B | B2B |
| Offering | Software, Hardware | Software |
| Founded | 2019 | 2016 |
| Headquarters | Tel Aviv, Israel | Jerusalem, Israel |
| Status | Active | Inactive |
Size, funding and growth
| Measure | PatenSee | Pomicell |
|---|---|---|
| Employees | 5 | 5 |
| Headcount growthLast 12 months | Not published | -29.7% |
| Total funding | Not published | $300K |
| Latest round | Bootstrapped | Seed |
| LinkedIn followers | 329 | 2,777 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | PatenSee | Pomicell |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 25/100 | 46/100 |
| Traction | 8/100 | 35/100 |
| Team | 30/100 | 50/100 |
| Search visibility | 27/100 | 36/100 |
| Quality | Not published | 52/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 8/100 | 4/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | PatenSee | Pomicell |
|---|---|---|
| CDN | Cloudflare | Not detected |
| CMS | WordPress | Wix |
| Frameworks | Jquery, Bootstrap | Not detected |
PatenSee vs Pomicell: common questions
Which is better, PatenSee or Pomicell?
On our 0-100 score Pomicell rates higher (46/100 against 25/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do PatenSee and Pomicell compare on the numbers?
PatenSee leads on agent readiness (39/100 against 21/100), domain rating (8/100 against 4/100). Pomicell leads on our overall score (46/100 against 25/100), LinkedIn following (2,777 against 329).
Read the full PatenSee review and pricing or the Pomicell review and pricing. You can also browse other PatenSee alternatives we track.